Atma oral drops dropper bottle 20 ml

The drug has a systemic therapeutic effect due to the combination and mutual strengthening of active components. has a broncholytic, mucolytic, anti-inflammatory, immunomodulatory and anti-allergic effect.

The drug eliminates spasm and reduces bronchial reactivity, reduces shortness of breath, reduces the frequency and intensity of asthma attacks. Improves the quantitative (production volume) and qualitative (physico-chemical) characteristics of sputum, promotes thinning and effective removal of thick mucus. Restores the work of the ciliated epithelium of the bronchi.

The anti-inflammatory effect of the drug prevents damage to the bronchi and lungs by free radicals and proteases, protects the pulmonary blood flow from the action of inflammatory mediators.

Reduces inflammatory infiltration and swelling of the mucous membrane, prevents the development of sclerotic changes in the bronchi and lungs. Improves the state of systemic immunity, normalizes the functional state of the cellular link and indicators of humoral immunity (IgE and CEC level), and also reduces the degree of antigenic stimulation. Contributes to the stabilization of mast cell membranes, reduces eosinophilia.

The drug increases the effectiveness of the complex therapy of BA. Strengthens the broncholytic effect of inhaled corticosteroids and β ₂ -agonists, allows to reduce the frequency of administration or the dose of drugs of basic therapy.

In the treatment of bronchitis, including obstructive, the drug reduces the severity of broncho-obstructive syndrome, helps improve the dynamics of clinical (including auscultatory symptoms, external respiratory function indicators, peak flowmetry data) and subjective manifestations.

In the treatment of chronic bronchitis, including smoker’s cough, it facilitates expectoration, improves breathing, general condition and quality of life, prevents the development of irreversible changes in the bronchi and lungs. Contributes to the rapid elimination of the asthenic symptom complex of hypoxic and infectious genesis. Stimulates individual compensatory capabilities of the body, increases non-specific reactivity and resistance of the body to infections. Improves psychometric parameters of patients’ quality of life.

Acute and chronic bronchitis, including with obstructive syndrome. in complex therapy ba.

Adults and children over 12 years old: 1 tablet or 10 drops of the drug in its pure form or diluted in 1 tablespoon of water;

children aged 5-12 years: ½ tablet;

children aged 2-12 years: 5 drops of the drug diluted in 1 tablespoon of water;

children under the age of 1 year: 1 drop of the drug diluted in 1 teaspoon of water or milk.

Take the drug 3 times a day – drops, 2 times a day – tablets.

At the beginning of treatment, as well as in cases requiring rapid relief of the symptoms of the disease, it is recommended to take the drug every 30 minutes-1 hour up to 8 times a day until the condition improves, but no more than 3 days, with the transition to a standard dose – 3 times a day .

To increase effectiveness, it is recommended to take the drug between meals (30 minutes before or 1 hour after a meal), holding the drug in the mouth for some time before swallowing.

Course of treatment: acute bronchitis – 2-4 weeks, chronic bronchitis – 4 weeks. Chronic obstructive bronchitis, bronchial asthma – 2-3 months.

Hypersensitivity to any of the components of the drug.

In exceptional cases, allergic reactions may occur in persons with hypersensitivity to any component of the drug.

At the beginning of the treatment, a short-term increase in the symptoms of the disease is possible, which indicates the effect of the drug, effective drainage of the bronchi and their cleansing of mucus. this exacerbation is a favorable sign that does not require discontinuation of the drug.

Since Atma contains plant and other natural components, slight changes in taste and smell or some turbidity of the solution are possible, which does not lead to a decrease in the effectiveness of the drug.

The drug in tablet form contains lactose, so patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should use the drug in the form of drops instead of Atma tablets.

Use during pregnancy and breastfeeding. There is no information on any risk for the fetus and child due to taking the drug during pregnancy and breastfeeding, but the appropriateness of using the drug is carried out taking into account the benefit / risk ratio, which is determined by the doctor.

Children. The drug in the form of drops is prescribed to children older than 2 years. Tablets – for children over 5 years old.

Clinically significant interaction with other pharmacological agents has not been established. the drug can be combined with any medicines and treatment methods.

Cases are unknown.

At a temperature not higher than 30 °C in a tightly closed bottle, in the original cardboard packaging in a place inaccessible to children.